Zabetian CP

References (2)

Title : The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study - Liu_2018_Lancet.Neurol_17_309
Author(s) : Liu SY , Wile DJ , Fu JF , Valerio J , Shahinfard E , McCormick S , Mabrouk R , Vafai N , McKenzie J , Neilson N , Perez-Soriano A , Arena JE , Cherkasova M , Chan P , Zhang J , Zabetian CP , Aasly JO , Wszolek ZK , McKeown MJ , Adam MJ , Ruth TJ , Schulzer M , Sossi V , Stoessl AJ
Ref : Lancet Neurol , 17 :309 , 2018
Abstract :
PubMedSearch : Liu_2018_Lancet.Neurol_17_309
PubMedID: 29456161

Title : Human PON1, a biomarker of risk of disease and exposure - Furlong_2010_Chem.Biol.Interact_187_355
Author(s) : Furlong CE , Suzuki SM , Stevens RC , Marsillach J , Richter RJ , Jarvik GP , Checkoway H , Samii A , Costa LG , Griffith A , Roberts JW , Yearout D , Zabetian CP
Ref : Chemico-Biological Interactions , 187 :355 , 2010
Abstract :
PubMedSearch : Furlong_2010_Chem.Biol.Interact_187_355
PubMedID: 20338154